CN110123896B - 一种辅助治疗肿瘤的药物组合物及其制备方法 - Google Patents
一种辅助治疗肿瘤的药物组合物及其制备方法 Download PDFInfo
- Publication number
- CN110123896B CN110123896B CN201910481896.2A CN201910481896A CN110123896B CN 110123896 B CN110123896 B CN 110123896B CN 201910481896 A CN201910481896 A CN 201910481896A CN 110123896 B CN110123896 B CN 110123896B
- Authority
- CN
- China
- Prior art keywords
- portions
- pharmaceutical composition
- tumor
- root
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 87
- 238000009098 adjuvant therapy Methods 0.000 title claims abstract description 53
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 52
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 31
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 18
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 17
- 241001474374 Blennius Species 0.000 claims abstract description 17
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 17
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 17
- 235000010842 Sarcandra glabra Nutrition 0.000 claims abstract description 17
- 240000004274 Sarcandra glabra Species 0.000 claims abstract description 17
- 235000016639 Syzygium aromaticum Nutrition 0.000 claims abstract description 17
- 244000223014 Syzygium aromaticum Species 0.000 claims abstract description 17
- 241000270666 Testudines Species 0.000 claims abstract description 17
- 235000006463 Brassica alba Nutrition 0.000 claims abstract description 16
- 244000140786 Brassica hirta Species 0.000 claims abstract description 16
- 235000011371 Brassica hirta Nutrition 0.000 claims abstract description 16
- 244000183685 Citrus aurantium Species 0.000 claims abstract description 16
- 235000007716 Citrus aurantium Nutrition 0.000 claims abstract description 16
- 235000006484 Paeonia officinalis Nutrition 0.000 claims abstract description 16
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 16
- 241000722953 Akebia Species 0.000 claims abstract description 13
- 241000213006 Angelica dahurica Species 0.000 claims abstract description 13
- 241000915604 Scutellaria barbata Species 0.000 claims abstract description 13
- 235000001188 Peltandra virginica Nutrition 0.000 claims abstract description 10
- 244000290970 Tetrapanax papyrifer Species 0.000 claims abstract description 9
- 244000170916 Paeonia officinalis Species 0.000 claims abstract 3
- 239000000203 mixture Substances 0.000 claims description 58
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 42
- 239000000706 filtrate Substances 0.000 claims description 32
- 238000002156 mixing Methods 0.000 claims description 28
- 239000000284 extract Substances 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- 238000001035 drying Methods 0.000 claims description 20
- 244000197580 Poria cocos Species 0.000 claims description 17
- 238000001914 filtration Methods 0.000 claims description 16
- 235000009811 Momordica charantia Nutrition 0.000 claims description 15
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 15
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 15
- 235000008434 ginseng Nutrition 0.000 claims description 15
- 239000006187 pill Substances 0.000 claims description 14
- 239000008187 granular material Substances 0.000 claims description 11
- 241000218989 Trichosanthes Species 0.000 claims description 10
- 244000302512 Momordica charantia Species 0.000 claims description 9
- 235000009812 Momordica cochinchinensis Nutrition 0.000 claims description 8
- 235000018365 Momordica dioica Nutrition 0.000 claims description 8
- 235000006533 astragalus Nutrition 0.000 claims description 8
- 229940107666 astragalus root Drugs 0.000 claims description 8
- 241000045403 Astragalus propinquus Species 0.000 claims description 7
- 235000008322 Trichosanthes cucumerina Nutrition 0.000 claims description 7
- 239000002775 capsule Substances 0.000 claims description 7
- 238000000227 grinding Methods 0.000 claims description 7
- 238000002791 soaking Methods 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 7
- 239000003826 tablet Substances 0.000 claims description 7
- 244000299790 Rheum rhabarbarum Species 0.000 claims description 6
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims description 6
- 235000007756 Akebia quinata Nutrition 0.000 claims description 3
- 240000008027 Akebia quinata Species 0.000 claims description 3
- 244000061520 Angelica archangelica Species 0.000 claims description 3
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 24
- 208000002193 Pain Diseases 0.000 abstract description 18
- 230000036407 pain Effects 0.000 abstract description 18
- 206010061218 Inflammation Diseases 0.000 abstract description 12
- 230000004054 inflammatory process Effects 0.000 abstract description 12
- 230000036039 immunity Effects 0.000 abstract description 10
- 230000008961 swelling Effects 0.000 abstract description 9
- 210000004881 tumor cell Anatomy 0.000 abstract description 9
- 235000015221 Bupleurum rotundifolium Nutrition 0.000 abstract description 6
- 244000236521 Bupleurum rotundifolium Species 0.000 abstract description 6
- 235000009818 Trichosanthes kirilowii Nutrition 0.000 abstract description 6
- 240000006023 Trichosanthes kirilowii Species 0.000 abstract description 6
- 230000005764 inhibitory process Effects 0.000 abstract description 6
- 241000894006 Bacteria Species 0.000 abstract description 5
- 238000009792 diffusion process Methods 0.000 abstract description 5
- 210000004185 liver Anatomy 0.000 abstract description 5
- 210000002784 stomach Anatomy 0.000 abstract description 5
- 210000000952 spleen Anatomy 0.000 abstract description 4
- 235000003889 Paeonia suffruticosa Nutrition 0.000 abstract description 2
- 240000005001 Paeonia suffruticosa Species 0.000 abstract description 2
- 230000000240 adjuvant effect Effects 0.000 abstract description 2
- 244000111489 Gardenia augusta Species 0.000 abstract 1
- 235000018958 Gardenia augusta Nutrition 0.000 abstract 1
- 244000248825 Peltandra virginica Species 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 241001106477 Paeoniaceae Species 0.000 description 13
- 238000002512 chemotherapy Methods 0.000 description 13
- 239000003814 drug Substances 0.000 description 11
- 241000219053 Rumex Species 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 10
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 201000011510 cancer Diseases 0.000 description 8
- 244000078912 Trichosanthes cucumerina Species 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 5
- 206010028813 Nausea Diseases 0.000 description 5
- 230000001976 improved effect Effects 0.000 description 5
- 230000008693 nausea Effects 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 238000001291 vacuum drying Methods 0.000 description 5
- 241000628997 Flos Species 0.000 description 4
- 241000282414 Homo sapiens Species 0.000 description 4
- 206010061428 decreased appetite Diseases 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 230000008673 vomiting Effects 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 208000005718 Stomach Neoplasms Diseases 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 230000003467 diminishing effect Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 206010017758 gastric cancer Diseases 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 201000011549 stomach cancer Diseases 0.000 description 3
- 230000004565 tumor cell growth Effects 0.000 description 3
- 210000004916 vomit Anatomy 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- UILPJVPSNHJFIK-UHFFFAOYSA-N Paeonol Chemical compound COC1=CC=C(C(C)=O)C(O)=C1 UILPJVPSNHJFIK-UHFFFAOYSA-N 0.000 description 2
- 241000180649 Panax notoginseng Species 0.000 description 2
- 235000003143 Panax notoginseng Nutrition 0.000 description 2
- 241000220261 Sinapis Species 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 241001061264 Astragalus Species 0.000 description 1
- 241000132012 Atractylodes Species 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 241000660877 Coridius Species 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- 244000008991 Curcuma longa Species 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 235000015489 Emblica officinalis Nutrition 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 235000007162 Ferula assa foetida Nutrition 0.000 description 1
- 244000228957 Ferula foetida Species 0.000 description 1
- 235000012850 Ferula foetida Nutrition 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 206010033372 Pain and discomfort Diseases 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000195474 Sargassum Species 0.000 description 1
- 241000967218 Selaginella tamariscina Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 244000277583 Terminalia catappa Species 0.000 description 1
- 235000011517 Terminalia chebula Nutrition 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 229940044683 chemotherapy drug Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000009950 gastric cancer growth Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- YLTGFGDODHXMFB-UHFFFAOYSA-N isoacetovanillon Natural products COC1=CC=C(C(C)=O)C=C1O YLTGFGDODHXMFB-UHFFFAOYSA-N 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 210000004324 lymphatic system Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000006996 mental state Effects 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 201000011591 microinvasive gastric cancer Diseases 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- MLIBGOFSXXWRIY-UHFFFAOYSA-N paeonol Natural products COC1=CC=C(O)C(C(C)=O)=C1 MLIBGOFSXXWRIY-UHFFFAOYSA-N 0.000 description 1
- 239000008517 radix Trichosanthis Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- 210000002229 urogenital system Anatomy 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 208000016261 weight loss Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/586—Turtles; Tortoises, e.g. terrapins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种辅助治疗肿瘤的药物组合物及其制备方法,辅助治疗肿瘤的药物组合物由鳖甲、草珊瑚、海藻、金银花、半枝莲、天花粉、栀子、三七、丹皮、白芥子、茯苓、白芍、通草、柴胡、木通、枳壳、当归、红花、丁香、无花果制备而成;本发明辅助治疗肿瘤的药物组合物具有极好的辅助作用,可以明显消肿止痛,疏肝健胃,理气和脾,抗菌消炎,显著增强肿瘤患者的身体免疫力,对肿瘤细胞有一定的抑制作用,可以防止肿瘤细胞进一步扩散。
Description
技术领域
本发明涉及中药组合物技术领域,具体为一种辅助治疗肿瘤的药物组合物及其制备方法。
背景技术
恶性肿瘤是目前社会比较常见的疾病,严重威胁人类健康。常见的恶性肿瘤经常发生在肺部、胃部等身体的各个系统,影响人类的正常生活,早期肿瘤通常采用手术治疗,但是手术治疗之后往往存在着复发和转移的风险,不能够完全治愈肿瘤;对于晚期肿瘤普遍采用化疗的方法,临床统计发现,化疗虽然可以抑制和杀死肿瘤细胞,但是也能杀死人体其他正常细胞,抑制骨髓造血功能,严重影响人类身体健康,而且化疗药物容易抑制身体免疫细胞,致使身体免疫功能下降,患者容易发生感染,难以康复。
中国专利CN102258712B公开了一种治疗肿瘤化疗后白细胞下降的药物组合物及制法,属于中药的技术领域。本组合物由刺五加、黄芪等药材组成,具有良好效果,但是对患者化疗后免疫力下降改善作用不明显。
中国专利CN104758748B公开了一种辅助肿瘤化疗的中药,可有效解决化疗后肿瘤患者普遍出现的免疫功能低下的问题,其解决的技术方案是,由以下原料药物制成:白术、茯苓、鸡内金、麦冬、玉竹、金刚刺、卷柏、藕节、皂角刺、抱树莲和阴地蕨,本发明白术、茯苓、鸡内金扶正固本,麦冬、玉竹清养肺胃,金刚刺、卷柏、藕节活血化淤,皂角刺、抱树莲、阴地蕨解毒化浊,在提高化疗患者机体免疫力方面,疗效肯定,是辅助肿瘤化疗的药物上的创新,但是,此发明,辅助治疗肿瘤化疗的中药的原料成本较高,不能普遍使用。
中国专利CN101352560B公开了一种以天然植物药材为主要药用成份的具有抗肿瘤的药物。本发明所述的治疗肿瘤的药物是由下述原料制成的口服药剂:阿魏、九香虫、丁香、木香、大黄、姜黄、诃子。本发明是依据各味药物的性味特点,提取有效成份,研制而成的服用方便的制剂。本发明所述药物主要用于对消化道恶性肿瘤、肺恶性肿瘤、乳腺恶性肿瘤、泌尿生殖系统肿瘤、头颈部恶性肿瘤、血液系统恶性肿瘤、淋巴系统恶性肿瘤的治疗,对其它恶性肿瘤具有辅助治疗作用,但是本发明抗肿瘤的药物药效单一,不能同时提高患者免疫力和辅助治疗恶性肿瘤,抑制肿瘤细胞生长扩散。
综上所述,如何提供一种辅助治疗肿瘤的药物组合物,既可以有效抑制肿瘤细胞、又可以缓解化疗对患者身体的伤害,同时具有较低的成本,是本领域技术人员急需解决的问题。
发明内容
针对现有技术的不足,本发明提供一种辅助治疗肿瘤的药物组合物,解决了目前用于辅助治疗肿瘤的药物治疗效果单一,成本较高,不能广泛应用的问题。
为了实现以上目的,本发明通过以下技术方案予以实现:
一种辅助治疗肿瘤的药物组合物,辅助治疗肿瘤的药物组合物由鳖甲、草珊瑚、海藻、金银花、半枝莲、天花粉、栀子、三七、丹皮、白芥子、茯苓、白芍、通草、柴胡、木通、枳壳、当归、红花、丁香、无花果制备而成。
上述原料中,鳖甲具有滋阴潜阳,软坚散结的作用,可以缓解病患的阴虚发热、头晕目眩症状;草珊瑚具有清热解毒、祛风止血、消肿止痛、抗菌消炎的作用,对身体损伤、创伤感染有明显的治疗作用,抗菌消炎,对肿瘤细胞的生长和扩散具有较好的抑制作用;海藻具有清热、软坚散结的作用,可以抗菌消炎、降低血脂、抗凝血,提高免疫力,增强患者体魄;金银花具有清热解毒、宣散风热、清解血毒的作用,可以避免肿瘤患者化疗后长时间高热、继发感染;半枝莲具有清热解毒、活血祛瘀、消肿止痛的作用,可以帮助肿瘤患者补充维生素和微量元素,增强身体素质,抵抗肿瘤;天花粉具有清热泻火、生津止渴、排脓消肿的作用,可以去热止渴、消除炎症,避免发生感染;栀子具有护肝、利胆、降压、镇静、止血、消肿的作用,可以缓解肿瘤患者的疼痛和不适,缓解病情;三七具有散结止血、消肿定痛的作用,可以缓解疼痛,散除结节、疏通经络、提高身体机能;丹皮含有的牡丹酚以及糖苷类成分均具有抗炎作用,可以镇静、降温、解读、镇痛、解痉,避免肿瘤患者发生炎症或者发生感染;白芥子具有温肺豁痰利气、散结通络止痛的作用,可以缓解肿瘤患者痰滞经络,关节麻木等症状;茯苓具有利水渗湿、健脾、宁心的作用,可以使肿瘤患者精心凝神,避免心浮气躁,可以安心调养;白芍具有平肝止痛、养血调经,敛阴止汗的作用,可以缓解肿瘤患者周身疼痛,增强身体素质,抑制肿瘤细胞生长;通草具有利水化湿的功效,可以疏散去热,镇痛;柴胡具有和解表里、疏肝升阳的作用,可以散热止痛,抑制肿瘤细胞生长、扩散;木通具有利尿通淋、清心除烦的作用,可以改善肿瘤患者的睡眠、提高精神状态;枳壳具有理气宽中、行滞消肿的功效,可以改善肿瘤患者脾胃虚弱症状,提高身体免疫力;当归具有补血和血、调经止痛、润燥滑肠的功效,还可以抵抗肿瘤,抑制肿瘤细胞生长和扩散、并且可以改善肿瘤患者的身体免疫力;红花具有活血通络、散瘀止痛、瘀带腹痛的功效,可以缓解肿瘤患者身体疼痛、感染发炎的症状;丁香具有抑菌止痛的功效,可以抑制发炎、增强身体素质;无花果具有健胃清肠、消肿解毒,对炎症和疼痛有明显的缓解作用,且可以缓解肿瘤患者食欲不振,身体免疫力低的症状,对肿瘤细胞具有一定的抑制作用。
进一步的,辅助治疗肿瘤的药物组合物组成及其重量份为:鳖甲3.5份~4.5份、草珊瑚8.5份~10.5份、海藻1.0份~1.4份、金银花3.2份~3.8份、半枝莲2.4份~2.9份、天花粉0.45份~0.85份、人参1.2份~1.8份、三七0.75份~0.95份、陈皮0.15份~0.25份、白芥子1.35份~2.35份、茯苓4.2份~4.8份、白芍5.4份~6.4份、通草6.0份~8.0份、柴胡4.8份~6.8份、木通8.3份~11.3份、枳壳0.32份~0.42份、当归4.7份~5.7份、红花4份~8份、丁香2份~6份、无花果7份~12份。
再进一步的,辅助治疗肿瘤的药物组合物还包括黄芪3.2份~4.2份、土大黄3份~6份、苦瓜2.3份~4.3份。
再进一步的,辅助治疗肿瘤的药物组合物组成及其重量份为:鳖甲3.7份~4.3份、草珊瑚9.0份~10.0份、海藻1.1份~1.3份、金银花3.3份~3.6份、半枝莲2.6份~2.8份、天花粉0.55份~0.75份、人参1.3份~1.7份、三七0.80份~0.90份、陈皮0.17份~0.22份、白芥子1.55份~2.05份、茯苓4.3份~4.7份、白芍5.7份~6.1份、通草6.5份~7.5份、柴胡5.1份~6.3份、木通8.8份~10.8份、枳壳0.36份~0.40份、当归4.9份~5.5份、红花5份~7份、丁香3份~5份、无花果8份~11份、黄芪3.4份~3.9份、土大黄4份~5份、苦瓜2.7份~4.0份。
本发明另一方面提供一种上述辅助治疗肿瘤的药物组合物的制备方法,包括以下步骤:
步骤一,所述重量份的鳖甲、苦瓜、土大黄和枳壳分别在温度为85℃~105℃条件下炙烤40分钟~50分钟,然后分别粉碎至60目~100目,混合得到组合物A,备用;
步骤二,所述重量份的人参、白芥子、丁香和无花果,分别干燥至水分含量为3.5%~5.5%,然后分别在温度为80℃~90℃的烘箱内烘烤45分钟~60分钟,然后混合研磨1.0小时~2.0小时,得到混合物B,备用;
步骤三,所述重量份的草珊瑚、海藻、金银花、半枝莲、三七、陈皮、茯苓、白芍、通草、柴胡、木通、当归、红花和黄芪混合后,粉碎至10目~30目,用乙醇浸泡1小时~1.5小时,滤过得到乙醇滤液,然后在滤渣中加水,在温度为90℃~95℃条件下煎煮15分钟~25分钟,滤过得滤液,重复两次,合并两次滤液与乙醇滤液,之后真空干燥得到浓缩浸膏,备用;
步骤四,步骤三得到的浓缩浸膏粉碎至80目~100目,然后加入步骤一得到混合物A、步骤二得到的混合物B和所述重量份的天花粉,搅拌混合5分钟~10分钟得到所述辅助治疗肿瘤的药物组合物。
进一步的,步骤一中,炙烤之前在温度为45℃~65℃条件下预热10分钟~20分钟。
进一步的,步骤二中,干燥过程为:首先在温度为35℃~45℃、风速为1.65米/秒~2.45米/秒条件下,干燥4小时~6小时,然后在温度为85℃~95℃、风速为0.45米/秒~0.95米/秒条件下,干燥3.5小时~4.5小时。
进一步的,步骤三中,加水量为滤渣的1.5倍~2.0倍。
再进一步的,步骤三中,浓缩浸膏水分含量为0.5%~1.0%。
进一步的,步骤四中,辅助治疗肿瘤的药物组合物可以制成片剂、胶囊剂、颗粒剂、水丸、蜜丸。
本发明的有益效果是:
(1)本发明辅助治疗肿瘤的药物组合物具有极好的辅助作用,可以明显消肿止痛,疏肝健胃,理气和脾,抗菌消炎,显著增强肿瘤患者的身体免疫力,对肿瘤细胞有一定的抑制作用,可以防止肿瘤细胞进一步扩散;
(2)本发明辅助治疗肿瘤的药物组合物对早期手术治疗肿瘤后的恢复过程中,可以明显止痛消炎,避免发炎感染,针对晚期化疗对身体产生的伤害有明显的改善,可以缓解身体疼痛、静心凝神、改善睡眠、镇静心绪,增强免疫力;
(3)本发明辅助治疗肿瘤的药物组合物原料价格低廉,制备方法简单,成本较低,适合普通肿瘤病患消费,可以广泛推广。
具体实施方式
为了使得本发明的技术方案的目的、技术方案和优点更加清楚,下文中将结合本发明具体实施方式,对本发明实施例的技术方案进行清楚、完整的描述。
应当说明的是,本发明所述的实施方式仅仅是实现本发明的优选方式,对属于本发明整体构思,而仅仅是显而易见的改动,均应属于本发明的保护范围之内。
实施例1
一种辅助治疗肿瘤的药物组合物
辅助治疗肿瘤的药物组合物组成及其重量份为:鳖甲3.5kg、草珊瑚8.5kg、海藻1.0kg、金银花3.2kg、半枝莲2.4kg、天花粉0.45kg、人参1.2kg、三七0.75kg、陈皮0.15kg、白芥子1.35kg、茯苓4.2kg、白芍5.4kg、通草6.0kg、柴胡4.8kg、木通8.3kg、枳壳0.32kg、当归4.7kg、红花4kg、丁香2kg、无花果7kg、黄芪3.2kg、土大黄3kg、苦瓜2.3kg。
通过如下方法制备:
步骤一,所述重量份的鳖甲、苦瓜、土大黄和枳壳分别在温度为45℃条件下预热10分钟之后在温度为85℃条件下炙烤40分钟,然后分别粉碎至60目,混合得到组合物A,备用;
步骤二,所述重量份的人参、白芥子、丁香和无花果,分别首先在温度为35℃、风速为1.65米/秒条件下,干燥4小时,然后在温度为85℃、风速为0.45米/秒条件下,干燥3.5小时至水分含量为3.5%,然后分别在温度为80℃的烘箱内烘烤45分钟,然后混合研磨1.0小时,得到混合物B,备用;
步骤三,所述重量份的草珊瑚、海藻、金银花、半枝莲、三七、陈皮、茯苓、白芍、通草、柴胡、木通、当归、红花和黄芪混合后,粉碎至10目,用乙醇浸泡1小时,滤过得到乙醇滤液,然后在滤渣中加水,在温度为90℃条件下煎煮15分钟,滤过得滤液,重复两次,合并两次滤液与乙醇滤液,之后真空干燥得到浓缩浸膏,备用;
其中,加水量为滤渣的1.5倍;浓缩浸膏水分含量为0.5%。
步骤四,步骤三得到的浓缩浸膏粉碎至80目,然后加入步骤一得到混合物A、步骤二得到的混合物B和所述重量份的天花粉,搅拌混合5分钟得到所述辅助治疗肿瘤的药物组合物。
其中,辅助治疗肿瘤的药物组合物可以制成片剂、胶囊剂、颗粒剂、水丸、蜜丸。
实施例2
一种辅助治疗肿瘤的药物组合物
辅助治疗肿瘤的药物组合物组成及其重量份为:鳖甲4.5kg、草珊瑚10.5kg、海藻1.4kg、金银花3.8kg、半枝莲2.9kg、天花粉0.85kg、人参1.8kg、三七0.95kg、陈皮0.25kg、白芥子2.35kg、茯苓4.8kg、白芍6.4kg、通草8.0kg、柴胡6.8kg、木通11.3kg、枳壳0.42kg、当归5.7kg、红花8kg、丁香6kg、无花果12kg、黄芪4.2kg、土大黄6kg、苦瓜4.3kg。
通过如下方法制备:
步骤一,所述重量份的鳖甲、苦瓜、土大黄和枳壳分别在温度为65℃条件下预热20分钟之后在温度为105℃条件下炙烤50分钟,然后分别粉碎至100目,混合得到组合物A,备用;
步骤二,所述重量份的人参、白芥子、丁香和无花果,分别首先在温度为45℃、风速为2.45米/秒条件下,干燥6小时,然后在温度为95℃、风速为0.95米/秒条件下,干燥4.5小时至水分含量为5.5%,然后分别在温度为90℃的烘箱内烘烤60分钟,然后混合研磨2.0小时,得到混合物B,备用;
步骤三,所述重量份的草珊瑚、海藻、金银花、半枝莲、三七、陈皮、茯苓、白芍、通草、柴胡、木通、当归、红花和黄芪混合后,粉碎至30目,用乙醇浸泡1.5小时,滤过得到乙醇滤液,然后在滤渣中加水,在温度为95℃条件下煎煮25分钟,滤过得滤液,重复两次,合并两次滤液与乙醇滤液,之后真空干燥得到浓缩浸膏,备用;
其中,加水量为滤渣的2.0倍;浓缩浸膏水分含量为1.0%。
步骤四,步骤三得到的浓缩浸膏粉碎至100目,然后加入步骤一得到混合物A、步骤二得到的混合物B和所述重量份的天花粉,搅拌混合10分钟得到所述辅助治疗肿瘤的药物组合物。
其中,辅助治疗肿瘤的药物组合物可以制成片剂、胶囊剂、颗粒剂、水丸、蜜丸。
实施例3
一种辅助治疗肿瘤的药物组合物
辅助治疗肿瘤的药物组合物组成及其重量份为:鳖甲3.7kg、草珊瑚9.0kg、海藻1.1kg、金银花3.3kg、半枝莲2.6kg、天花粉0.55kg、人参1.3kg、三七0.80kg、陈皮0.17kg、白芥子1.55kg、茯苓4.3kg、白芍5.7kg、通草6.5kg、柴胡5.1kg、木通8.8kg、枳壳0.36kg、当归4.9kg、红花5kg、丁香3kg、无花果8kg、黄芪3.4kg、土大黄4kg、苦瓜2.7kg。
通过如下方法制备:
步骤一,所述重量份的鳖甲、苦瓜、土大黄和枳壳分别在温度为50℃条件下预热12分钟之后在温度为90℃条件下炙烤42分钟,然后分别粉碎至70目,混合得到组合物A,备用;
步骤二,所述重量份的人参、白芥子、丁香和无花果,分别首先在温度为37℃、风速为1.85米/秒条件下,干燥4.5小时,然后在温度为88℃、风速为0.55米/秒条件下,干燥4.5小时至水分含量为4.0%,然后分别在温度为82℃的烘箱内烘烤47分钟,然后混合研磨1.2小时,得到混合物B,备用;
步骤三,所述重量份的草珊瑚、海藻、金银花、半枝莲、三七、陈皮、茯苓、白芍、通草、柴胡、木通、当归、红花和黄芪混合后,粉碎至30目,用乙醇浸泡1.5小时,滤过得到乙醇滤液,然后在滤渣中加水,在温度为91℃条件下煎煮17分钟,滤过得滤液,重复两次,合并两次滤液与乙醇滤液,之后真空干燥得到浓缩浸膏,备用;
其中,加水量为滤渣的1.6倍;浓缩浸膏水分含量为0.6%。
步骤四,步骤三得到的浓缩浸膏粉碎至100目,然后加入步骤一得到混合物A、步骤二得到的混合物B和所述重量份的天花粉,搅拌混合6分钟得到所述辅助治疗肿瘤的药物组合物。
其中,辅助治疗肿瘤的药物组合物可以制成片剂、胶囊剂、颗粒剂、水丸、蜜丸。
实施例4
一种辅助治疗肿瘤的药物组合物
辅助治疗肿瘤的药物组合物组成及其重量份为:鳖甲4.3kg、草珊瑚10.0kg、海藻1.3kg、金银花3.6kg、半枝莲2.8kg、天花粉0.75kg、人参1.7kg、三七0.90kg、陈皮0.22kg、白芥子2.05kg、茯苓4.7kg、白芍6.1kg、通草7.5kg、柴胡6.3kg、木通10.8kg、枳壳0.40kg、当归5.5kg、红花7kg、丁香5kg、无花果11kg、黄芪3.9kg、土大黄5kg、苦瓜4.0kg。
通过如下方法制备:
步骤一,所述重量份的鳖甲、苦瓜、土大黄和枳壳分别在温度为63℃条件下预热18分钟之后在温度为101℃条件下炙烤48分钟,然后分别粉碎至90目,混合得到组合物A,备用;
步骤二,所述重量份的人参、白芥子、丁香和无花果,分别首先在温度为43℃、风速为2.25米/秒条件下,干燥5.5小时,然后在温度为93℃、风速为0.85米/秒条件下,干燥3.5小时至水分含量为5.0%,然后分别在温度为88℃的烘箱内烘烤57分钟,然后混合研磨1.8小时,得到混合物B,备用;
步骤三,所述重量份的草珊瑚、海藻、金银花、半枝莲、三七、陈皮、茯苓、白芍、通草、柴胡、木通、当归、红花和黄芪混合后,粉碎至10目,用乙醇浸泡1小时,滤过得到乙醇滤液,然后在滤渣中加水,在温度为94℃条件下煎煮23分钟,滤过得滤液,重复两次,合并两次滤液与乙醇滤液,之后真空干燥得到浓缩浸膏,备用;
其中,加水量为滤渣的1.8倍;浓缩浸膏水分含量为0.9%。
步骤四,步骤三得到的浓缩浸膏粉碎至80目,然后加入步骤一得到混合物A、步骤二得到的混合物B和所述重量份的天花粉,搅拌混合8分钟得到所述辅助治疗肿瘤的药物组合物。
其中,辅助治疗肿瘤的药物组合物可以制成片剂、胶囊剂、颗粒剂、水丸、蜜丸。
实施例5
一种辅助治疗肿瘤的药物组合物
辅助治疗肿瘤的药物组合物组成及其重量份为:鳖甲4.0kg、草珊瑚9.5kg、海藻1.2kg、金银花3.5kg、半枝莲2.7kg、天花粉0.65kg、人参1.5kg、三七0.85kg、陈皮0.19kg、白芥子1.85kg、茯苓4.5kg、白芍5.9kg、通草7.0kg、柴胡5.6kg、木通9.8kg、枳壳0.39kg、当归5.2kg、红花6kg、丁香4kg、无花果10kg、黄芪3.7kg、土大黄4.5kg、苦瓜3.4kg。
通过如下方法制备:
步骤一,所述重量份的鳖甲、苦瓜、土大黄和枳壳分别在温度为55℃条件下预热15分钟之后在温度为95℃条件下炙烤45分钟,然后分别粉碎至80目,混合得到组合物A,备用;
步骤二,所述重量份的人参、白芥子、丁香和无花果,分别首先在温度为40℃、风速为2.05米/秒条件下,干燥5小时,然后在温度为90℃、风速为0.75米/秒条件下,干燥4.0小时至水分含量为4.5%,然后分别在温度为85℃的烘箱内烘烤54分钟,然后混合研磨1.5小时,得到混合物B,备用;
步骤三,所述重量份的草珊瑚、海藻、金银花、半枝莲、三七、陈皮、茯苓、白芍、通草、柴胡、木通、当归、红花和黄芪混合后,粉碎至20目,用乙醇浸泡1.2小时,滤过得到乙醇滤液,然后在滤渣中加水,在温度为93℃条件下煎煮20分钟,滤过得滤液,重复两次,合并两次滤液与乙醇滤液,之后真空干燥得到浓缩浸膏,备用;
其中,加水量为滤渣的1.7倍;浓缩浸膏水分含量为0.8%。
步骤四,步骤三得到的浓缩浸膏粉碎至90目,然后加入步骤一得到混合物A、步骤二得到的混合物B和所述重量份的天花粉,搅拌混合8分钟得到所述辅助治疗肿瘤的药物组合物。
其中,辅助治疗肿瘤的药物组合物可以制成片剂、胶囊剂、颗粒剂、水丸、蜜丸。
实验例
测试1:在无菌条件下,选取60只ICR小鼠,注射接种相同条件的胃癌细胞悬液,待ICR小鼠长出3mm左右的肿瘤后,将ICR小鼠随机分为6组,对实验组50只ICR小鼠用药为本发明制备的辅助治疗肿瘤的药物组合物,用量为20mg/Kg;对照组10只ICR小鼠用药为生理盐水,用量为20ml/Kg。其中,用药10天为一个疗程、每日一次,计算一个疗程后实验组的肿瘤抑制率,其中,肿瘤抑制率=(对照组平均肿瘤重量-实验组平均肿瘤重量)/对照组平均肿瘤重量×100%;计算结果见表1:
表1本发明制备的辅助治疗肿瘤的药物组合物的胃癌肿瘤抑制率
从表1结果可以看出本发明实施例1~5制备的辅助治疗肿瘤的药物组合物对胃癌肿瘤细胞的生长有明显的抑制作用,可用于辅助治疗肿瘤疾病,同时原料成本较低,适合普通病患。
测试2:结合服用本发明辅助治疗肿瘤的药物组合物制成的颗粒剂的肿瘤患者,进一步说明本发明治疗效果。
用法:口服;用量:每日3次,每次10g;规格10g/袋。
治疗例1:患者王某某,女,48岁,经检查为早期胃癌,伴有恶心、呕吐、食欲不振等症状,连续服用本发明颗粒剂7天后,恶心症状明显改善,饮食规律正常,睡眠质量好转,患者治疗有效。
治疗例2:患者李某,男,62岁,经检查为晚期肺癌,化疗后伴有恶心、呕吐、食欲不振、体重下降、失眠多梦、体乏无力等症状,连续服用本发明颗粒剂7天后,体乏无力症状明显改善,睡眠规律正常,患者治疗有效。
治疗例3:患者王某,女,41岁,经检查为晚期胃癌,化疗后伴有恶心、呕吐、食欲不振、失眠多梦,免疫力下降,极易感冒等症状,连续服用本发明颗粒剂7天后,恶心呕吐、失眠多梦症状明显改善,饮食规律,身体免疫力明显提高,精力旺盛,患者治疗有效。
以上仅为本发明的优选实施例而已,并不用于限制本发明,对于本领域的技术人员来说,本发明可以有各种更改和变化。凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。
Claims (6)
1.一种辅助治疗肿瘤的药物组合物,其特征在于,所述辅助治疗肿瘤的药物组合物组成及其重量份为:鳖甲3.7份~4.3份、草珊瑚9.0份~10.0份、海藻1.1份~1.3份、金银花3.3份~3.6份、半枝莲2.6份~2.8份、天花粉0.55份~0.75份、人参1.3份~1.7份、三七0.80份~0.90份、陈皮0.17份~0.22份、白芥子1.55份~2.05份、茯苓4.3份~4.7份、白芍5.7份~6.1份、通草6.5份~7.5份、柴胡5.1份~6.3份、木通8.8份~10.8份、枳壳0.36份~0.40份、当归4.9份~5.5份、红花5份~7份、丁香3份~5份、无花果8份~11份、黄芪3.4份~3.9份、土大黄4份~5份、苦瓜2.7份~4.0份;所述的辅助治疗肿瘤的药物组合物的制备方法,步骤如下:
步骤一,所述重量份的鳖甲、苦瓜、土大黄和枳壳分别在温度为85℃~105℃条件下炙烤40分钟~50分钟,然后分别粉碎至60目~100目,混合得到组合物A,备用;
步骤二,所述重量份的人参、白芥子、丁香和无花果,分别干燥至水分含量为3.5%~5.5%,然后分别在温度为80℃~90℃的烘箱内烘烤45分钟~60分钟,然后混合研磨1.0小时~2.0小时,得到混合物B,备用;
步骤三,所述重量份的草珊瑚、海藻、金银花、半枝莲、三七、陈皮、茯苓、白芍、通草、柴胡、木通、当归、红花和黄芪混合后,粉碎至10目~30目,用乙醇浸泡1小时~1.5小时,滤过得到乙醇滤液,然后在滤渣中加水,在温度为90℃~95℃条件下煎煮15分钟~25分钟,滤过得滤液,重复两次,合并两次滤液与乙醇滤液,之后真空干燥得到浓缩浸膏,备用;
步骤四,步骤三得到的浓缩浸膏粉碎至80目~100目,然后加入步骤一得到混合物A、步骤二得到的混合物B和所述重量份的天花粉,搅拌混合5分钟~10分钟得到所述辅助治疗肿瘤的药物组合物。
2.如权利要求1所述的辅助治疗肿瘤的药物组合物,其特征在于,步骤一中,所述炙烤之前在温度为45℃~65℃条件下预热10分钟~20分钟。
3.如权利要求1所述的辅助治疗肿瘤的药物组合物,其特征在于,步骤二中,所述干燥过程为:首先在温度为35℃~45℃、风速为1.65米/秒~2.45米/秒条件下,干燥4小时~6小时,然后在温度为85℃~95℃、风速为0.45米/秒~0.95米/秒条件下,干燥3.5小时~4.5小时。
4.如权利要求1所述的辅助治疗肿瘤的药物组合物,其特征在于,步骤三中,所述加水量为滤渣的1.5倍~2.0倍。
5.如权利要求1所述的辅助治疗肿瘤的药物组合物,其特征在于,步骤三中,所述浓缩浸膏水分含量为0.5%~1.0%。
6.如权利要求1所述的辅助治疗肿瘤的药物组合物,其特征在于,步骤四中,所述辅助治疗肿瘤的药物组合物为片剂、胶囊剂、颗粒剂、水丸、蜜丸。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910481896.2A CN110123896B (zh) | 2019-06-04 | 2019-06-04 | 一种辅助治疗肿瘤的药物组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910481896.2A CN110123896B (zh) | 2019-06-04 | 2019-06-04 | 一种辅助治疗肿瘤的药物组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110123896A CN110123896A (zh) | 2019-08-16 |
CN110123896B true CN110123896B (zh) | 2021-11-16 |
Family
ID=67580076
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910481896.2A Active CN110123896B (zh) | 2019-06-04 | 2019-06-04 | 一种辅助治疗肿瘤的药物组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110123896B (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101023992A (zh) * | 2007-03-26 | 2007-08-29 | 河南仲景药业股份有限公司 | 治疗乳腺增生病的药物 |
-
2019
- 2019-06-04 CN CN201910481896.2A patent/CN110123896B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101023992A (zh) * | 2007-03-26 | 2007-08-29 | 河南仲景药业股份有限公司 | 治疗乳腺增生病的药物 |
Also Published As
Publication number | Publication date |
---|---|
CN110123896A (zh) | 2019-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111375010A (zh) | 一种具有扶正固本,补肝益肾,增强免疫功效的中药组合物 | |
CN101569739B (zh) | 一种治疗胆囊炎的中药组合物及其制备方法 | |
CN103127326A (zh) | 一种治疗骨关节炎的药物组合物及其制备方法 | |
CN115282229B (zh) | 一种治疗气虚血淤型冠心病的中药组合物及其制备方法 | |
CN101954022B (zh) | 一种用于治疗肺癌的中药组合物 | |
CN110123896B (zh) | 一种辅助治疗肿瘤的药物组合物及其制备方法 | |
CN104042981A (zh) | 一种治疗产后便秘的药剂及制备方法 | |
CN103735871A (zh) | 一种治疗神经衰弱的中药组合物及其制备方法 | |
CN102579677A (zh) | 一种治疗脑胶质瘤的中药组合物 | |
CN105106634A (zh) | 一种治疗急性阑尾炎的中药制剂及其应用 | |
CN104398975A (zh) | 一种治疗乳腺纤维瘤的中药制剂及其制备方法 | |
CN104623381A (zh) | 一种用于治疗血热肝郁所致的皮肤病的中药组合物 | |
CN105412755A (zh) | 缓解肿瘤病人放疗反应的药剂胶囊的制备方法 | |
CN103656199B (zh) | 一种治疗肾阴不足证型咳嗽的中药 | |
CN102166303B (zh) | 一种治疗慢性萎缩性胃炎的中药组合物 | |
CN100534473C (zh) | 一种内服治疗牙痛的中药组合物 | |
CN105327157A (zh) | 一种治疗脑血管堵塞的中药及其制备方法 | |
CN104784547A (zh) | 对放疗具有增效作用的中药组合物及制备方法 | |
CN103830611B (zh) | 一种治疗麻毒陷肺证型肺炎的中药 | |
CN104524535A (zh) | 一种治疗慢性肺源性心脏病的中药组合物及其制备方法 | |
CN111821385A (zh) | 养生保健酒 | |
CN113694173A (zh) | 一种治疗痛经的中药组合物及其制备方法和应用 | |
CN103655935A (zh) | 一种治疗乙肝的中药组合物 | |
CN103599271A (zh) | 一种治疗子宫肌瘤的中药 | |
CN113144139A (zh) | 治疗癌症的中药组合物及其制备方法和应用以及中药制品 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |